NASDAQ:BLTE

Belite Bio Stock Predictions

etoro logo Buy BLTE
*Your capital is at risk
$137.23
+2.30 (+1.70%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

BLTE Prediction Chart

BLTE Predictions History

Latest community submissions for BLTE.
Predictor Target Session Target Price Result Direction Accuracy Score
Dec 31, 2025 $157.47 -2.08% $159.96 V 98.44% 1
Dec 31, 2025 $158.73 -1.30% $159.96 V 99.23% 3
Dec 31, 2025 Bullish $159.96 X 0
Dec 30, 2025 Bullish $160.82 X 0
Sep 5, 2023 $34.13 +3.43% $34.90 V 97.80% 1
Sep 5, 2023 $33.71 +2.14% $34.90 V 96.58% 1
JS JS Pro
Sep 5, 2023 $32.38 -1.88% $34.90 X 92.78% 0
Aug 29, 2023 $34.24 -3.00% $36.64 X 93.45% 0
Aug 29, 2023 $34.64 -1.88% $36.64 X 94.53% 0
Aug 29, 2023 Bullish $36.64 V 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for BLTE with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT BELITE BIO, INC
Belite Bio
Belite Bio, Inc, a clinical-stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics targeting atrophic age-related macular degeneration and autosomal recessive stargardt diseases. Its lead product candidate is LBS-008, an oral once-a-day treatment that can reduce and maintain the delivery of vitamin A to the eye to reduce the accumulation of toxic vitamin A by-products in ocular tissue that ...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE